Nanoemulsion formulations for tumor-targeted delivery

Nanotechnology for Cancer Therapy

Volumn , Issue , 2006, Pages 723-739

  Tiwari, Sandip B ^a   Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85132538020     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Salager, J. L., Formulation concepts for the emulsion maker, In Pharmaceutical Emulsions and Suspensions, Nielloud, F. and Marti-Mestres, G., Eds., Marcel Dekker, New York, pp. 19-72, 2000.
2. Tenjarla, S., Microemulsions: An overview and pharmaceutical applications, Crit. Rev. Ther. Drug Carrier Syst., 16(5), 461-521, 1999.
3. Keipert, S., Siebenbrodt, I., Luders, F., and Bornschein, M., Microemulsions and their potential pharmaceutical application, Pharmazie, 44(7), 433-144, 1989.
4. Schoot, H., Colloidal dispersions, In Remington: The Science and Practice of Pharmacy, Gennaro, A., Lippincott, R., Ed., 20th ed., Williams &Witkins, Maryland, pp. 288-315, 2000.
5. Sarker, D. K., Engineering of nanoemulsions for drug delivery, Curr. Drug Deliv., 2(4), 297-310, 2000.
6. Jores, K., Lipid nanodispersions as drug carrier systems -a physicochemical characterization, http://sundoc.bibliothek.uni-halle.de/diss-online/04/04H310/prom.pdf, accessed date, Aug. 16, 2005.
7. Buszello, K. and Muller, B., Emulsions as drug delivery systems, In Pharmaceutical Emulsions and Suspensions, Nielloud, F. and Marti-Mestres, G., Eds., Marcel Dekker, New York, pp. 191-228, 2000.
8. Yang, S. C. and Benita, S., Enhanced absorption and drug targeting by positively charged submicron emulsions, Drug Dev. Res., 50, 476-486, 2000.
9. Inactive ingredient search for approved drug products, http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm, date accessed, Nov. 05, 2005.
10. Eccleston, G., Emulsions, In Encyclopedia of Pharmaceutical Technology, Swarbrick, J. and Boylan, J., Eds., Marcel Dekker, New York, pp. 137-188, 1992.
11. Chung, H., Kim, T. W., Kwon, M., Kwon, I. C., and Jeong, S. C., Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system, J. Control Release, 71, 339-350, 2001.
12. Allison, A. D., Squelene and squalane emulsions as adjuvants, Methods, 19, 87-93, 1999.
13. Lane, T. A., Perfluorochemical-based artificial oxygen carrying red cell substitutes, Transfus. Sci., 16(1), 19-31, 1995.
14. Benita, S. and Levy, M. Y., Submicron emulsions as colloidal drug carrieres for intravenous administration: Comprehensive physicochemical characterization, J. Pharm. Sci., 82, 1069-1079, 1993.
15. Klang, S. and Benita, S., Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration, In Submicron Emulsions in Drug Targeting and Delivery, Benita, S., Ed., Academic Publishers, Harwood, pp. 119-152, 1998.
16. Klang, S., Frucht-Pery, J., Hoffman, A., and Benita, S., Physicochemical characterization and acute toxicity evaluation of apositively charged submicron emulsion vehicle, J. Pharm. Pharmacol., 46, 986-993, 1998.
17. Haskell, R., Nanotechnology for drug delivery, www.banyu-zaidan.or.jp/symp/soyaku/haskell.pdf, date accessed, Oct. 06, 2005.
18. Haskell, R. J., Characterization of submicron systems via optical methods, J. Pharm. Sci., 87(2), 125-129, 1998.
19. Wabel, C., Influence of lecithin on structure and stability of parenteral fat emulsions, http://www2.chemie.uni-erlangen.de/services/dissonline/data/dissertation/Christoph_Wabel/html/index.html, accessed date Oct. 09 2005.
20. Salager, J. L., Emulsionpropertiesand relate know-how andattainthem, In Pharmaceutical Emulsions and Suspensions, Nielloud, F. andMarti-Mestres, G., Eds., MarcelDekker, NewYork, pp.73-125, 2000.
21. Gaysorn, C., Lyons, R. T., Patel, M. V., and Hem, S. L., Effect of surface charge on the stability of oil/water emulsions during steam sterilization, J. Pharm. Sci., 88(4), 454-458, 1999.
22. Elbaz, E., Zeevi, A., Klang, S., and Benita, S., Positively charged submicron emulsions- anew type of colloidal drug carrier, Int. J. Pharm., 96, R1-R6, 1993.
23. Klang, S. H., Siganos, C. S., Benita, S., and Frucht-Pery, J., Evaluation of apositively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn, J. Control Release, 57(1), 19-27, 1999.
24. Klang, S. H., Frucht-Pery, J., Hoffman, A., and Benita, S., Physicochemical characterization and acute toxicity evaluation of apositively-charged submicron emulsion vehicle, J. Pharm. Pharmacol., 46(12), 986-993, 1994.
25. Gershanik, T., Benzeno, S., and Benita, S., Interaction of aself-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as afunction of droplet size and surface charge, Pharm. Res., 15(6), 863-869, 1998.
26. Oku, N., Tokudome, Y., Namba, Y., Saito, N., Endo, M., Hasegawa, Y., Kawai, M., Tsukada, H., and Okada, S., Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography, Biochim. Biophys. Acta, 1280(1), 149-154, 1996.
27. Gao, X. and Huang, L., Anovel cationic liposome reagent for efficient transfection of mammalian cells, Biochem. Biophys. Res. Commun., 179(1), 280-285, 1991.
28. Calvo, P., Alonso, M. J., Vila-Jato, J. L., and Robinson, J. R., Development of positively charged colloidal drug carrieres: Chitosan coated polyester nanocapsules and sub-micron emulsions, Colloid Polm. Sci., 275, 46-53, 1997.
29. Jumaa, M. and Muller, B. W., Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process, Int. J. Pharm., 183(2), 175-184, 1999.
30. Samama, J. P., Lee, K. M., and Biellmann, J. F., Enzymes and microemulsions: Activity and kinetic properties of liver alcohol dehydrogenase in ionic water in oil microemulsions, Eur. J. Biochem., 163, 609-617, 1987.
31. Kurihara, A., Shibayama, Y., Mizota, A., Yasuno, A., Ikeda, M., and Hisaoka, M., Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats, Biol. Pharm. Bull., 19(2), 252-258, 1996.
32. Lundberg, B. B., Preparation of drug carrier emulsions stabilized with phosphatidylcholine surfactant mixtures, J. Pharm. Sci., 83, 72-75, 1994.
33. Liu, F. and Liu, D., Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs, Pharm. Res., 12(7), 1060-1064, 1995.
34. Hodoshima, N., Udagawa, C., Ando, T., Fukuyasu, H., Watanabe, T., and Nakabayashi, S., Lipid nanoparticles for delivering antitumor drugs, Int. J. Pharm., 146, 81-92, 1997.
35. Kurihara, A., Shibayama, Y., Mizota, A., Yasuno, A., Ikeda, M., Sasagawa, K., Kobayashi, T., and Hisaoka, M., Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice, Pharm. Res., 13(2), 305-310, 1996.
36. Davis, S. S., Washington, C., West, P., Illum, L., Liversidge, G., Sternson, L., and Kirsh, R., Lipid emulsions as drug delivery systems, Ann. N.Y. Acad. Sci., 507, 75-88, 1987.
37. Arimoto, I., Matsumoto, C., Tanaka, M., Okuhira, K., Saito, H., and Handa, T., Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions, Lipids, 33(8), 773-779, 1998.
38. Krobbuaban, B., Diregpoke, S., Kumkeaw, S., and Tanomsat, M., Comparison on pain on injection of asmall particle size-lipid emulsion of propofol and standard propofol with or without lidocaine, J. Med. Assoc. Thai., 88(10), 1401-1405, 2005.
39. Thorn-Alquist, A. M., Parenteral use of diazepam in an emulsion formulation. Aclinical study, Acta Anaesthesiol. Scand, 21(5), 400-104, 1977.
40. Westrin, P., Jonmarker, C., and Werner, O., Dissolving methohexital in alipid emulsion reduces pain associated with intravenous injection, Anesthesiology, 76(6), 930-934, 1992.
41. Lovell, M. W., Johnson, H. W., Hui, H. W., Cannon, J. B., Gupta, P. K., and Hsu, C. C., Less-painful emulsion formulations for intravenous administration of clarithomycin, Int. J. Pharm., 109, 45-57, 1994.
42. Stuttmann, H., Doenicke, A., Kugler, J., and Laub, M., Anew formulation of etomidate in lipid emulsion: Bioavailability and venous irritation, Anaesthesist, 38, 421-423, 1989.
43. Glen, J. B. and Hunter, S. C., Pharmacology of an emulsion formulation of ICI 35 868, Br. J. Anaesth., 56(6), 617-626, 1984.
44. Jang, S. H., Wientjes, M. G., Lu, D., and Au, J. L., Drug delivery and transport to solid tumors, Pharm. Res., 20(9), 1337-1350, 2003.
45. Mayhew, E. G., Lasic, D., Babbar, S., and Martin, F. J., Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating apolyethylene glycol-derivatized phospholipid, Int. J. Cancer, 51(2), 302-309, 1992.
46. Lundberg, B. B., Asubmicron lipid emulsion coated with amphipathic polyethylene glycol for parenteral administration of paclitaxel (Taxol), J. Pharm. Pharmacol., 49(1), 16-21, 1997.
47. Constantinides, P. P., Lambert, K. J., Tustian, A. K., Schneider, B., Lalji, S., Ma, W., Wentzel, B., Kessler, D., Worah, D., and Quay, S. C., Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel, Pharm. Res., 17(2), 175-182, 2000.
48. Kan, P., Chen, Z. B., Lee, C. J., and Chu, I. M., Development of nonionic surfactant/phospholipid o/w emulsion as apaclitaxel delivery system, J. Control Release, 58(3), 271-278, 1999.
49. Lundberg, B. B., Sub-micron lipid emulsions as carrieres for anticancer drugs, http://www.cmbl.org.pl/lundberg.pdf, accessed date, Sept. 25, 2005.
50. Teixeira, H., Dubernet, C., Chacun, H., Rabinovich, L., Boutet, V., Deverre, J. R., Benita, S., and Couvreur, P., Cationic emulsions improves the delivery of oligonucleotides to leukemic P388/ADR cells in ascite, J. Control Release, 89(3), 473-482, 2003.
51. Teixeira, H., Dubernet, C., Puisieux, F., Benita, S., and Couvreur, P., Submicron cationic emulsions as anew delivery system for oligonucleotides, Pharm. Res., 16(1), 30-36, 1999.
52. Teixeira, H., Dubernet, C., Rosilio, V., Laigle, A., Deverre, J. R., Scherman, D., Benita, S., and Couvreur, P., Factors influencing the oligonucleotides release from O-W submicron cationic emulsions, J. Control Release, 70(1-2), 243-255, 2001.
53. Teixeira, H., Rosilio, V., Laigle, A., Lepault, J., Erk, I., Scherman, D., Benita, S., Couvreur, P., and Dubernet, C., Characterization of oligonucleotide/lipid interactions in submicron cationic emulsions: Influence of the cationic lipid structure and the presence of PEG-lipids, Biophys. Chem., 92(3), 169-181, 2001.
54. Lee, M. K., Chun, S. K., Choi, W. J., Kim, J. K., Choi, S. H., Kim, A., Oungbho, K., Park, J. S., Ahn, W. S., and Kim, C. K., The use of chitosan as acondensing agent to enhance emulsion-mediated gene transfer, Biomaterials, 26(14), 2147-2156, 2005.
55. Goldstein, D., Nassar, T., Lambert, G., Kadouche, J., and Benita, S., The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates, J. Control Release, 108(2-3), 418-432, 2005.
56. Lundberg, B. B., Griffiths, G., and Hansen, H., Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions, J. Pharm. Pharmacol., 51(10), 1099-1105, 1999.
57. Waldow, S. M., Henderson, B. W., and Dougherty, T. J., Hyperthermic potentiation of photodynamic therapy employing Photofrin Iand II: Comparison of results using three animal tumor models, Lasers Surg. Med., 7(1), 12-22, 1987.
58. Dougherty, T. J., Photosensitizers: therapy and detection of malignant tumors, Photochem. Photobiol., 45(6), 879-889, 1987.
59. Potter, W. R., Mang, T. S., and Dougherty, T. J., The theory of photodynamic therapy dosimetry: Consequences of photo-destruction of sensitizer, Photochem. Photobiol., 46(1), 97-101, 1987.
60. Morgan, A. R., Garbo, G. M., Keck, R. W., and Selman, S. H., New photosensitizers for photody-namic therapy: Combined effect of metallopurpurin derivatives and light on transplantable bladder tumors, Cancer Res., 48(1), 194-198, 1988.
61. Reddi, E., Role of delivery vehicles for photosensitizers in the photodynamic therapy of tumours, J. Photochem. Photobiol. B, 37(3), 189-195, 1997.
62. Woodburn, K., Chang, C. K., Lee, S., Henderson, B., and Kessel, D., Biodistribution and PDT efficacy of aketochlorin photosensitizer as afunction of the delivery vehicle, Photochem. Photobiol., 60(2), 154-159, 1994.
63. Soncin, M., Polo, L., Reddi, E., Jori, G., Kenney, M. E., Cheng, G., and Rodgers, M. A., Effect of the delivery system on the biodistribution of Ge(IV) octabutoxy-phthalocyanines in tumour-bearing mice, Cancer Lett., 89(1), 101-106, 1995.
64. Soncin, M., Polo, L., Reddi, E., Jori, G., Kenney, M. E., Cheng, G., and Rodgers, M. A., Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines, Br. J. Cancer, 71(4), 727-732, 1995.
65. Wohrle, D., Muller, S., Shopova, M., Mantareva, V., Spassova, G., Vietri, F., Ricchelli, F., and Jori, G., Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methy-loxyethyleneoxy) silicon-phthalocyanine in tumor-bearing mice, J. Photochem. Photobiol. B, 50(2-3), 124-128, 1999.
66. The basics of boron neutron capture therapy, http://web.mit.edu/nrl/www/bnct/info/description/description.html, date accessed, Nov. 27, 2005.
67. Shawer, M., Greenspan, P., OIe, S., and Lu, D. R., VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting, J. Pharm. Sci., 91(6), 1405-1413, 2002.
68. Miyamoto, M., Hirano, K., Ichikawa, H., Fukumori, Y., Akine, Y., and Tokuuye, K., Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutron-capture therapy with tumor-bearing hamsters, Biol. Pharm. Bull., 22(12), 1331-1340, 1999.
69. Miyamoto, M., Hirano, K., Ichikawa, H., Fukumori, Y., Akine, Y., and Tokuuye, K., Preparation of Gadolinium-containing emulsions stabilized with phosphatidylcholine surfactant mixtures for neutron capture therapy, Chem. Pharm. Bull. (Tokyo), 47(2), 203-208, 1999.
70. Watanabe, T., Ichikawa, H., and Fukumori, Y., Tumor accumulation of gadolinium in lipid-nanopar-ticles intravenously injected for neutron-capture therapy of cancer, Eur. J. Pharm. Biopharm., 54(2), 119-124, 2002.
71. Teicher, B. A., Use of perfluorochemical emulsions in cancer therapy, Biomater. Artif. Cells Immobil. Biotechnol., 20(2-4), 875-882, 1992.
72. Teicher, B. A., Herman, T. S., and Frei, E., Perfluorochemical emulsions: Oxygen breathing in radiation sensitization and chemotherapy modulation, Important Adv. Oncol., 39-59, 1992.
73. Teicher, B. A., Holden, S. A., Ara, G., Ha, C. S., Herman, T. S., and Northey, D., Anew concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents, J. Cancer Res. Clin. Oncol., 118(7), 509-514, 1992.
74. Rockwell, S., Irvin, C. G., and Nierenburg, M., Effect of aperfluorochemical emulsion on the development of artificial lung metastases in mice, Clin. Exp. Metastasis, 4(1), 45-50, 1986.
75. Sisk, J., Imaging cancer one nanometer at atime, http://www.radiologytoday.net/imagingcancer.htm, accessed date, Sept. 06, 2005.
76. Schmieder, A. H., Winter, P. M., Caruthers, S. D., Harris, T. D., Williams, T. A., Allen, J. S., and Lacy, E. K., Molecular MR imaging of melanoma angiogenesis with alphanubeta-3-targeted paramagnetic nanoparticles, Magn. Reson. Med., 53(3), 621-627, 2005.